Showing results (291-300 of 667) with videos related to

Sort By:
Pageof 67
Hemasphere|August 2, 2023
Nationwide Assessment of Patient Trajectories in Mantle Cell Lymphoma: The Swedish MCLcomplete ProjectMats Jerkeman, Sara Ekberg, Ingrid Glimelius, et al.
Hemasphere|July 31, 2023
Emerging Strategies in 3D Culture Models for Hematological CancersDafne Barozzi, Cristina Scielzo
Hemasphere|June 26, 2023
Emerging Epigenetic and Posttranslational Mechanisms Controlling Resistance to Glucocorticoids in Acute Lymphoblastic LeukemiaCristina Borin, Tim Pieters, Valentina Serafin, et al.
Hemasphere|September 7, 2023
CAR-T in the Treatment of Acute Myeloid Leukemia: Barriers and How to Overcome ThemJolien Vanhooren, Rani Dobbelaere, Charlotte Derpoorter, et al.
Hemasphere|February 26, 2026
Intra-subtype heterogeneity shapes treatment response in KMT2A-rearranged ALL across all age groupsAlina M Hartmann, Lorenz Bastian, Malwine J Barz, et al.
Hemasphere|March 9, 2026
The European CAR-T map-Current status and future directions to improve access to CAR T-cell therapy for hematologic malignanciesElise R A Pennings, Frederick W Thielen, Florence Broussais, et al.
Hemasphere|February 26, 2026
Health Care Utilization Databases obtained from health system inform outcome for ruxolitinib treatment in patients with myelofibrosisBarbara Mora, Matteo Franchi, Ludovica Margotto, et al.
Hemasphere|April 10, 2026
Erdheim-Chester disease associated with myeloid neoplasm: Clinical features, molecular landscape, and treatment outcomesAmbroise Le Pogam, Matthias Papo, Pierre Hirsch, et al.
Hemasphere|April 6, 2026
Correction to "Outcomes of patients with relapsed or refractory primary mediastinal B-cell lymphoma treated with anti-CD19 CAR-T cells: CARTHYM, a study from the French national DESCAR-T registry"
Hemasphere|April 20, 2026
Biological and clinical characteristics of ETV6::RUNX1-like ALLMarketa Zaliova, Dagmar Schinnerl, Judith M Boer, et al.
Pageof 67